ArticleJournal of robotic surgery2025
Maximal anatomic bladder neck preservation at the prostatic origin (MANO) in robotic radical prostatectomy: does prostate size matter?
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Predicting extraperitoneal ssRARP difficulty: an MRI-based nomogram.Journal of robotic surgery · 2026Article
- Editorial Comment: Maximal anatomic bladder neck preservation at the prostatic origin (MANO) in robotic radical prostatectomy: does prostate size matter?International braz j urol : official journal of the Brazilian Society of UrologyArticle
- Robot-Assisted Partial Nephrectomy is the Hot Topic in this Number of International Brazilian Journal of Urology.International braz j urol : official journal of the Brazilian Society of UrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate size has traditionally been considered a determinant of surgical difficulty and postoperative outcomes in radical prostatectomy. Larger glands often present challenges in bladder neck dissection, with potential implications for continence and oncological safety. We describe the maximal anatomic bladder neck preservation at the prostatic origin (MANO) technique, designed to enable safe circumferential dissection at the true bladder neck origin irrespective of gland size. This retrospective study analyzed 341 patients undergoing nerve-sparing robotic-assisted radical prostatectomy (RALP) with the MANO technique between 2017 and 2023. Patients were stratified into three groups by MRI-estimated prostate volume: < 30 cc (n = 83), 30-50 cc (n = 147), and > 50 cc (n = 111). Perioperative, pathological, functional, and oncological outcomes were compared. Continence was defined as 0-1 pad/day, assessed at 3, 12, and 24 months. Larger prostates were associated with older age and higher preoperative PSA (p < 0.05). Mean operative time increased with gland size (165.2 vs. 191.5 min, p < 0.001), and hospital stay was longer for > 50 cc prostates (p = 0.003). Blood loss showed a non-significant increase with prostate size. Pathological stage, Gleason grade, and margin status were comparable across groups. Early continence at 3 months was similar (≈71% across cohorts, p = 0.607), with > 85% continent at 12 months in all groups. Biochemical recurrence rates did not differ significantly (p = 0.630). Complications were infrequent, with no ureteric injuries reported. The MANO technique enables safe bladder neck preservation across all prostate sizes. Despite increased operative complexity in larger glands, functional and oncological outcomes remain equivalent. This approach may standardize bladder neck management in RALP and support improved continence recovery irrespective of prostate volume.
Indexed as
Identifiers
41125940What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.